Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.

Also called NCT02089464

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 199 participants (enrolled count) (from the registry)
Sponsor
Nexstim Ltd (from the registry)
Registry
  • NCT NCT02089464
Main results
  • Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke Stroke, 2018-09 DOI, PubMed 30354990

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02089464. Randomized; triple masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2016-05 (actual). Results posted on 2020-09-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Acronym
NICHE
Condition
Stroke
Intervention (Device)
NBS-guided rTMS
Intervention (Device)
Sham rTMS
Intervention (Procedure)
Task oriented rehabilitation
Lead sponsor
Nexstim Ltd (class: industry)

Record details

Record id
cardio:ct-nct02089464
Content hash
0b1b4d3492246081231c686ccd612425dc93682c93f52f5481c2839fd5dc61d4